Replies to post #211418 on Cytodyn Inc (CYDY)

[theswordman]

This is what shareholders were told Thurs JUN 30 2022

" Our initial time frame of 8-12 weeks, was dependent on us being provided data from former CRO according to industry standards. In the process of analyzing the data, in conjunction with our pharmacovigilance experts, we realized we needed to convert the data into industry standard format. To be clear, We have the data. It is really a data conversion issue. "

So since at least FEB of 2020--CYDY has been aware of a "data conversion" issue
The nodder says shareholders paid 1.5 million $$ extra to convert data to proper format for BLA (< FEB 2020)

So 2 1/2 years later shareholders are being told the same old sad story--won't be 2-3 months--now don't know how long it will be. And people voted for nodder?? And people voted for naydenov?? And people voted for kelly??

Oh people

And now they want MORE shares--after blowing thru 200 million extra shares since NOV 2021. Less than 8 months. And for what?? Covid trials in Brazil--NOPE. BLA submission--NOPE. BTD for TNBC--NOPE. Longhauler trial--NOPE.

But kelly did get a nice trip to London. Nodder is still getting paid. PR firms getting paid. Lawyers getting paid. Board still full pay. Good job working to restore credibility and advance Leronlimab

[Bill_ENG]

So they may have been told that by the crooked CRO in 2020. But it is impossible that the Cytodyn management would have known this in 2020 to the detail that they know it now.

It's very simple to acknowledge that they did not have the Trial Data in 2020.

They just got their hands on the data from the audit this year, so in what world would anyone think they are talking about the same thing ?

Jmo